<code id='325D16A6CC'></code><style id='325D16A6CC'></style>
    • <acronym id='325D16A6CC'></acronym>
      <center id='325D16A6CC'><center id='325D16A6CC'><tfoot id='325D16A6CC'></tfoot></center><abbr id='325D16A6CC'><dir id='325D16A6CC'><tfoot id='325D16A6CC'></tfoot><noframes id='325D16A6CC'>

    • <optgroup id='325D16A6CC'><strike id='325D16A6CC'><sup id='325D16A6CC'></sup></strike><code id='325D16A6CC'></code></optgroup>
        1. <b id='325D16A6CC'><label id='325D16A6CC'><select id='325D16A6CC'><dt id='325D16A6CC'><span id='325D16A6CC'></span></dt></select></label></b><u id='325D16A6CC'></u>
          <i id='325D16A6CC'><strike id='325D16A6CC'><tt id='325D16A6CC'><pre id='325D16A6CC'></pre></tt></strike></i>

          Home / Wikipedia / focus

          focus


          focus

          author:fashion    Page View:929
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In